LU83962A1 - Nouveau compose utile comme medicament antitussif et son procede de preparation - Google Patents
Nouveau compose utile comme medicament antitussif et son procede de preparation Download PDFInfo
- Publication number
- LU83962A1 LU83962A1 LU83962A LU83962A LU83962A1 LU 83962 A1 LU83962 A1 LU 83962A1 LU 83962 A LU83962 A LU 83962A LU 83962 A LU83962 A LU 83962A LU 83962 A1 LU83962 A1 LU 83962A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- compound
- preparation
- antitussitive
- compound useful
- novel compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT934381 | 1981-02-25 | ||
| IT8109343A IT1210639B (it) | 1981-02-25 | 1981-02-25 | Prodotto: 3(4-fenil1piperazinio-1-il)-1,2-propandiolo 3(teofillin-7-il)-1propansolfonato,utilizzabile in terapia,e relativo procedimento di fabbricazione |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU83962A1 true LU83962A1 (fr) | 1982-07-08 |
Family
ID=11128724
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU83962A LU83962A1 (fr) | 1981-02-25 | 1982-02-23 | Nouveau compose utile comme medicament antitussif et son procede de preparation |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4372958A (it) |
| JP (1) | JPS57188589A (it) |
| AT (1) | AT380881B (it) |
| BE (1) | BE892271A (it) |
| CA (1) | CA1192549A (it) |
| CH (1) | CH651043A5 (it) |
| DE (1) | DE3205149A1 (it) |
| DK (1) | DK148687C (it) |
| ES (1) | ES8302680A1 (it) |
| FR (1) | FR2500455A1 (it) |
| GB (1) | GB2093445B (it) |
| GR (1) | GR76060B (it) |
| IT (1) | IT1210639B (it) |
| LU (1) | LU83962A1 (it) |
| NL (1) | NL8200746A (it) |
| PT (1) | PT74463B (it) |
| SE (1) | SE440503B (it) |
| YU (1) | YU44007B (it) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1203721B (it) * | 1983-12-29 | 1989-02-23 | Dompe Farmaceutici Spa | Composti otticamente attivi ad attivita' antitosse e sedativa centrale,procedimento per la preparazione e composizioni che li contengono |
| IT1217950B (it) * | 1988-06-28 | 1990-03-30 | Dott Formenti Ind Chimica E Fa | Sali di (r,s) 3 (4 fenil 1 piperazinil) 1,2 propandtolo |
| IT1231158B (it) * | 1989-07-20 | 1991-11-19 | Dompe Farmaceutici Spa | Procedimento per la risoluzione ottica della dropropizina. |
| DE3938123A1 (de) * | 1989-11-16 | 1991-05-23 | Diehl Gmbh & Co | Treibladungsanzuender |
| IT1318651B1 (it) * | 2000-07-28 | 2003-08-27 | Dompe Spa | Sintesi di (+-)1,3-diossolani e loro risoluzione ottica. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3163649A (en) * | 1964-12-29 | Substituteb phenyl-piperazine | ||
| GB938646A (en) * | 1961-03-16 | 1963-10-02 | Henri Morren | New piperazine derivatives |
| FR1384693A (fr) * | 1963-10-08 | 1965-01-08 | Electrochimie Soc | Procédé de préparation d'esters méthallyliques |
| FR1554628A (it) * | 1967-05-23 | 1969-01-24 |
-
1981
- 1981-02-25 IT IT8109343A patent/IT1210639B/it active
- 1981-05-22 GB GB8115803A patent/GB2093445B/en not_active Expired
- 1981-06-10 US US06/272,281 patent/US4372958A/en not_active Expired - Fee Related
-
1982
- 1982-02-13 DE DE19823205149 patent/DE3205149A1/de active Granted
- 1982-02-17 AT AT0059982A patent/AT380881B/de not_active IP Right Cessation
- 1982-02-19 PT PT74463A patent/PT74463B/pt unknown
- 1982-02-23 LU LU83962A patent/LU83962A1/fr unknown
- 1982-02-23 GR GR67396A patent/GR76060B/el unknown
- 1982-02-24 ES ES509850A patent/ES8302680A1/es not_active Expired
- 1982-02-24 DK DK79982A patent/DK148687C/da active
- 1982-02-24 CA CA000397008A patent/CA1192549A/en not_active Expired
- 1982-02-24 NL NL8200746A patent/NL8200746A/nl not_active Application Discontinuation
- 1982-02-24 YU YU412/82A patent/YU44007B/xx unknown
- 1982-02-24 JP JP57027570A patent/JPS57188589A/ja active Granted
- 1982-02-25 CH CH1167/82A patent/CH651043A5/it not_active IP Right Cessation
- 1982-02-25 FR FR8203164A patent/FR2500455A1/fr active Granted
- 1982-02-25 BE BE0/207403A patent/BE892271A/fr not_active IP Right Cessation
- 1982-02-25 SE SE8201184A patent/SE440503B/sv not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| YU44007B (en) | 1990-02-28 |
| DK148687B (da) | 1985-09-02 |
| IT1210639B (it) | 1989-09-14 |
| YU41282A (en) | 1987-10-31 |
| GB2093445B (en) | 1985-02-27 |
| FR2500455A1 (fr) | 1982-08-27 |
| ES509850A0 (es) | 1983-02-01 |
| ATA59982A (de) | 1985-12-15 |
| JPS57188589A (en) | 1982-11-19 |
| DK79982A (da) | 1982-08-26 |
| DK148687C (da) | 1986-04-28 |
| ES8302680A1 (es) | 1983-02-01 |
| CH651043A5 (it) | 1985-08-30 |
| CA1192549A (en) | 1985-08-27 |
| BE892271A (fr) | 1982-06-16 |
| GB2093445A (en) | 1982-09-02 |
| AT380881B (de) | 1986-07-25 |
| DE3205149A1 (de) | 1982-11-11 |
| NL8200746A (nl) | 1982-09-16 |
| PT74463B (en) | 1983-08-24 |
| JPH0333715B2 (it) | 1991-05-20 |
| PT74463A (en) | 1982-03-01 |
| IT8109343A0 (it) | 1981-02-25 |
| SE8201184L (sv) | 1982-08-26 |
| GR76060B (it) | 1984-08-03 |
| SE440503B (sv) | 1985-08-05 |
| FR2500455B1 (it) | 1984-04-27 |
| US4372958A (en) | 1983-02-08 |
| DE3205149C2 (it) | 1991-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4072759A (en) | Novel benzylalcohol derivatives as antidiabetics and cardiotonics | |
| BG65924B1 (bg) | Хидрохлоридни соли на 5 - [4-[2-(n-метил-n-[2-пиридил]амино] етокси] бензил] тиазолидин - 2, 4 - дион | |
| EP0154756B1 (fr) | Citrate de vinpocetine et son procédé de préparation | |
| FI96421B (fi) | Menetelmä substituoidun karboksyylihapon farmaseuttisesti käyttökelpoisen kodeiinisuolan valmistamiseksi | |
| HU206110B (en) | Process for producing azelatine salts with improved solubility and pharmaceutical compositions comprising same | |
| JPS62212322A (ja) | 医薬組成物および処置法 | |
| LU83962A1 (fr) | Nouveau compose utile comme medicament antitussif et son procede de preparation | |
| EP0001021A2 (fr) | Nouveaux dérivés d'alcaloides pentacycliques, procédé de préparation, application à la synthèse de produits du groupe de l'éburnamonine et compositions pharmaceutiques | |
| JPS59144763A (ja) | １−〔１−ベンズイミダゾリル〕−ｎ−〔２−（４−ヒドロキシ−３−メトキシフエニル）−２−ヒドロキシエチル〕−３−アミノブタン化合物、該化合物を含有する医薬、及び該化合物の製 | |
| LU83928A1 (fr) | Acides amino-2 halogenobenzoyl-3 methyphenylacetiques et leurs esters et sels utiles comme medicaments anti-inflammatoires et analgesiques | |
| UA52661C2 (uk) | Безводна кристалічна форма гідрохлориду r(-)-n-(4,4-ди(3-метилтієн-2-іл)бут-3-еніл) ніпекотинової кислоти | |
| FR2827284A1 (fr) | Nouveaux derives de n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| CH641775A5 (fr) | N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, son procede de preparation et composition le renferment. | |
| US7763625B2 (en) | Agents for treating migraine | |
| WO2002078710A1 (fr) | Medicaments contre l'hyperactivite vesicale | |
| FR2527605A1 (fr) | Derives de piperazine, procede de fabrication et medicaments en resultant | |
| FR2468598A1 (fr) | Thiazolidones-4 substituees en 2, leur procede de preparation et les medicaments les contenant | |
| DE3812755A1 (de) | Salicylsaeurederivate | |
| US4349547A (en) | Suppressing obesity and over-secretion of insulin with 2-(α-hydroxy-m-trifluoromethylbenzyl)azetidine | |
| US5039679A (en) | Certain derivatives of 1,4-dihydro-5-isopropoxy-1,6-naphthyridine-3-carboxylic acid, pharmaceutical compositions containing them, and methods of using them | |
| JPS58219160A (ja) | 特に心臓血管系において活性であるトリプタミンの新しい誘導体、およびこの物質の合成方法、およびこの物質を含む薬品 | |
| CA1223595A (fr) | Derives de (quinolyl-4)-1 (piperidyl-4)-2 ethanamine et de (quinolyl-4)-1 (piperidyl-4)-3 propanamine, procedes pour leur preparation et medicaments les contenant | |
| US3737540A (en) | Composition for suppressing the tremor of parkinson's syndrome | |
| CH628321A5 (en) | Process for the preparation of derivatives of isobutyramide and medical composition containing these derivatives | |
| DE2026402C3 (de) | Derivate der 5- (2- [(l-Methyl-3- phenylpropyl)amino] -äthyl} -salicylsäure, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneipräparate |